Komzifti
Active substance: ziftomenib
CAPSULE · ZIFTOMENIB 200 mg/1
United StatesActive
Marketing holder: Kura Oncology, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ZIFTOMENIB · 200 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-e202-75be-be7b-7f5c5d6f3fc0;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 84696-200
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 84696-200 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 84696-200 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 84696-200 · Verified 2026-10-09 · open in source